Birgitte Kringelum Breindal

Title: The Innovative Contributions of Birgitte Kringelum Breindal

Introduction

Birgitte Kringelum Breindal, an accomplished inventor based in Kolding, Denmark, has significantly contributed to the field of nicotine delivery systems. With a focus on improving the stability and efficacy of oral dosage forms, her groundbreaking work stands out in the pharmaceutical industry.

Latest Patents

Birgitte holds a patent for a nicotine delivery product, which encompasses nicotine-loaded cation exchange resin particles. This invention comprises at least 50% (w/w) particles within the size range of 90-300 microns, thereby enhancing nicotine stability in oral dosage forms. The patent not only outlines the product but also details methods for producing the nicotine delivery product, along with its various applications.

Career Highlights

Birgitte is currently associated with Fertin Pharma A/S, a notable company in the pharmaceutical sector. Her role at Fertin Pharma showcases her dedication to advancing health-related innovations through research and development.

Collaborations

Throughout her career, Birgitte has collaborated with esteemed colleagues, including Jesper Thorsen and Bjarne Vestbö. These partnerships have fostered an environment of creativity and innovation, enabling her to achieve remarkable results in her field.

Conclusion

The contributions of Birgitte Kringelum Breindal to the development of nicotine delivery products are exemplary of her expertise and commitment to innovation. Her patent reflects not just a technical achievement but also a step forward in improving therapeutic options for nicotine delivery, marking her as an influential figure in the pharmaceutical landscape.